entertainment -WSS

entertainment

author：fashion 2025-10-04 11:57:24 - browse：91355

Mayo Clinic, in Rochester, Minnesota on — Photo by KEREM YUCEL/AFP via Getty Images

SAN FRANCISCO — Mayo Clinic has signed Silicon Valley tech startup Cerebras as its first generative AI partner, the health system announced Monday.

The health system — known for its cutting-edge research and willingness to partner with tech companies — will give Cerebras millions of dollars to help build technology tools based on Mayo’s trove of de-identified patient data, leaders announced at the J.P. Morgan Healthcare Conference. Mayo and Cerebras did not disclose the dollar amount, but Cerebras said it was a multimillion, multi-year contract.

With roughly 380 employees, Cerebras builds and sells supercomputers specifically designed for AI applications across several industries — pitting the upstart in direct competition with the market leader Nvidia Corp. Life sciences giants including GSK have used its technology for drug discovery, and it has partnered with a health network in United Arab Emirates, but this is Cerebras’ first AI contract with a U.S. health system. The deal gives Mayo access to Cerebras’ supercomputers as well as a Cerebras team to help develop health-tuned models; Mayo will then own whatever they build.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Chris Christie meets with Zelenskyy during Ukraine trip

explore

WSS

AI models in health care face new federal disclosure requirements

Despite FDA approval for Lyfgenia, Bluebird faces stiff competition

How to ethically and practically extend health care to all

How I helped Pfizer think through the ethics of Viagra

FAA sets up new process for Hawaii air tour operators to fly at lower altitudes after fatal crashes

Judge partially blocks Texas abortion ban for medical emergencies, fatal diagnoses

entertainment

entertainment

knowledge

DIEP, the 'gold standard' of breast reconstruction, is under threat

2 officers injured in shooting in Orlando, police say

Medical leaders decry Supreme Court decision on affirmative action

Spinal cord stimulation reduces pain in amputees, study finds

State Dept. review finds Biden bears some blame for Afghanistan failures

Pfizer plans to depart BIO

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Roche to buy Carmot Therapeutics, developer of obesity drugs

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Chemotherapy shortages won’t get better under Biden’s latest plan

focus

Patients' immediate access to test results puts radiologists in a bind

Alnylam reports growth in sales of rare disease treatments

FDA needs staff influx to meet gene therapy needs, Marks says

Why sickle cell disease is getting the first CRISPR treatment

STAT Event – Decoding Clinical Trials: Venture Capitalists Talk Early Biotech R&D

The cancer stories no one wants to hear

entertainment

explore

explore

focus